HomeENTA • NASDAQ
add
Enanta Pharmaceuticals Inc
Previous close
$13.86
Day range
$13.82 - $14.19
Year range
$4.09 - $17.15
Market cap
403.08M USD
Avg Volume
222.36K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 18.62M | 9.76% |
Operating expense | 29.87M | -26.26% |
Net income | -11.94M | 46.44% |
Net profit margin | -64.13 | 51.21% |
Earnings per share | -0.42 | 60.00% |
EBITDA | -10.02M | 55.76% |
Effective tax rate | -0.20% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 185.85M | -14.23% |
Total assets | 329.50M | -5.49% |
Total liabilities | 202.91M | -14.32% |
Total equity | 126.59M | — |
Shares outstanding | 29.02M | — |
Price to book | 3.18 | — |
Return on assets | -9.22% | — |
Return on capital | -9.61% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -11.94M | 46.44% |
Cash from operations | -11.70M | 30.37% |
Cash from investing | -47.30M | -168.64% |
Cash from financing | 64.14M | 1,386.32% |
Net change in cash | 5.14M | -89.09% |
Free cash flow | -6.66M | 72.42% |
About
Founded
1995
Headquarters
Website
Employees
120
